文献速递主动脉疾病

贫血与完整腹主动脉瘤开放及腔内修复术后结局

Anemia and postoperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2019-01-23

基于血管质量倡议数据库(2008-2017)的回顾性分析,纳入34,397例完整腹主动脉瘤修复患者。中重度贫血(<10 g/dL)在EVAR中与30天死亡(OR 2.65)及肾、心、呼吸并发症风险升高相关,但在OAR中多因素分析后无此关联。轻度贫血亦与EVAR后30天死亡及肾、呼吸并发症风险升高相关。

要点

  • EVAR术前中重度贫血与30天死亡、肾、心、呼吸并发症风险独立相关。
  • OAR中贫血与30天死亡及院内结局在多因素分析后无独立关联。
  • EVAR轻度贫血患者术前输血与院内主要不良心脏事件风险加倍相关。

核心结论

  • 术前贫血与EVAR术后30天死亡及院内不良结局风险升高相关,但与OAR术后无此关联。

研究设计与样本

  • 回顾性分析血管质量倡议数据库(2008-2017)中34,397例完整腹主动脉瘤修复患者。
  • 排除术前红细胞增多症、破裂动脉瘤及输注>4单位浓缩红细胞者。
  • 血红蛋白分为中重度贫血(<10 g/dL)、轻度贫血(女性10-12 g/dL,男性10-13 g/dL)和无贫血(女性>12 g/dL,男性>13 g/dL)。
  • 采用多因素logistic模型和粗化精确匹配分析贫血与30天死亡及院内主要并发症的关联。

主要发现

  • 28.5%患者有轻度贫血,4.3%有中重度贫血。
  • OAR(n=6112)和EVAR(n=28,285)中,中重度贫血患者院内不良事件(死亡、心梗、肾、呼吸并发症、再手术)及30天死亡率均更高。
  • 多因素分析及1:1粗化精确匹配后,OAR中贫血与30天死亡及其他院内结局无关联。
  • EVAR中中重度贫血与30天死亡(OR 2.65;95%CI 1.69-4.18)、肾脏并发症(OR 2.47;95%CI 1.78-3.43;P<.05)、急性充血性心衰(OR 1.96;95%CI 1.18-3.25)和呼吸并发症(OR 2.01;95%CI 1.26-3.19)相关。
  • EVAR轻度贫血亦与30天死亡及肾、呼吸并发症风险升高相关;轻度贫血患者术前输血与院内主要不良心脏事件(卒中、死亡、心梗)风险加倍相关(OR 2.1;95%CI 1.38-3.11;P<.001)。

临床怎么用

  • EVAR术前应将贫血纳入风险分层评估。
  • 对EVAR患者,中重度贫血提示术后死亡及并发症风险显著升高。

局限性

  • 回顾性数据库研究,可能存在未测量混杂。
  • 需未来研究评估药物治疗改善贫血患者术后结局的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anemia is associated with increased cardiac adverse events during the early postoperative period because of high physiologic stress and increased cardiac demand. The aim of this study was to assess the surgical outcomes and prognostic implications of anemia in patients undergoing repair of intact abdominal aortic aneurysms (AAAs). METHODS: A retrospective analysis of all patients who underwent open aortic repair (OAR) or endovascular aneurysm repair (EVAR) in the Vascular Quality Initiative database (2008-2017) was performed. Patients with preoperative polycythemia, patients with ruptured aneurysms, and patients transfused with >4 units of packed red blood cells were excluded. Hemoglobin levels were categorized into three groups: moderate-severe anemia (<10 g/dL), mild anemia (10-12 g/dL in women and 10-13 g/dL in men), and no anemia (>12 g/dL in women and >13 g/dL in men). Multivariate logistic models and coarsened exact matching were used to analyze the association between anemia and 30-day mortality and between anemia and major in-hospital complications after OAR and EVAR. RESULTS: A total of 34,397 patients were identified undergoing AAA repair. Of those, 28.5% had mild anemia and 4.3% had moderate-severe anemia. In both OAR (n = 6112) and EVAR (n = 28,285), patients with moderate-severe anemia had significantly higher rates of in-hospital adverse events, such as in-hospital mortality, myocardial infarction, renal and respiratory complications, and reoperation, compared with patients with mild or no anemia. They also had higher rates of 30-day mortality. After multivariate analysis and 1:1 coarsened exact matching, no association was found between anemia and 30-day mortality and other in-hospital outcomes in patients undergoing OAR. On the other hand, in EVAR, moderate-severe anemia was associated with 2.7 times the odds of 30-day mortality (odds ratio [OR], 2.65; 95% confidence interval [CI], 1.69-4.18), 2.5 times the odds of renal complications (OR, 2.47; 95% CI, 1.78-3.43; P < .05), and twice the risk of acute congestive heart failure (OR, 1.96; 95% CI, 1.18-3.25) and respiratory complications (OR, 2.01; 95% CI, 1.26-3.19). Mild anemia was also associated with increased odds of 30-day mortality and renal and respiratory complications in patients undergoing EVAR. Interestingly, preoperative blood transfusion in mildly anemic patients undergoing EVAR was associated with double the odds of in-hospital major adverse cardiac events (stroke, death, and myocardial infarction; OR, 2.1; 95% CI, 1.38-3.11; P < .001). CONCLUSIONS: Preoperative anemia is associated with higher odds of 30-day mortality and in-hospital adverse outcomes after EVAR but not after OAR. These findings highlight the need to incorporate anemia into the preoperative risk assessment of patients undergoing EVAR. Future studies are needed to assess the efficacy of medical therapies in improving postoperative outcomes in anemic patients undergoing AAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dakour-Aridi H, Nejim B, Locham S, et al. Anemia and postoperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms. J Vasc Surg. 2019. PMID: 30685198. doi:10.1016/j.jvs.2018.05.233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。